Please assess the completion status of the following clinical trial:

Trial Title: Home Hypnotherapy for Refractory Functional Chest Pain: A Pilot Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18 to 80, male or female.~* Patients must fulfill the Rome III criteria for Functional Chest Pain of Presumed Esophageal Origin for the previous 3 months (with symptom onset at least 6 months before diagnosis), including all of the following:~  * Midline chest pain or discomfort that is not of burning quality~ * Absence of evidence that gastroesophageal reflux is the cause of the symptom~ * Absence of histopathology-based esophageal motility disorders~* Persistent symptoms despite a trial of antidepressant therapy, as defined by either:~  * chest pain despite at least a continuous 4-week trial of at least one antidepressant within the last 6 months; or~ * intolerance of at least one antidepressant within the last 6 months.~* Negative cardiac evaluation (negative cardiac stress test or negative coronary angiogram)~* Negative gastrointestinal evaluation for cause of the pain, defined by absence of Los Angeles grade C or D erosive esophagitis on endoscopy, persistent chest pain on PPI therapy, and no association of chest pain with reflux episodes on an ambulatory pH or pH-impedance study, defined as a symptom index \<50% or symptom association probability \<95% for chest pain .~Exclusion Criteria:~* Severe co-morbid illness (cardiac, pulmonary, renal, hematologic, hepatic)~* Prior treatment with hypnosis/hypnotherapy for a medical condition~* Prior major thoracic surgery~* Prior diagnosis of or treatment for dissociative disorders, post-traumatic stress disorder, borderline personality disorder, or other psychiatric disorders that include psychotic features~* Pregnancy or planned pregnancy within the upcoming 3 months~* Inability or unwillingness to give informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Hypnotherapy (Type: EXPERIMENTAL): Participants will be randomized to either the home hypnotherapy or educational group. The HHT protocol will consist of sequences of two different types of sessions, longer biweekly sessions (LS), each approximately 30-40 minutes in length, and shorter daily sessions (SS), approximately 12 minutes in length. On the first day of each sequence, the patient will listen to the appropriate LS. The patients will listen to the SS on a daily basis in between each LS. Every 2 weeks a new sequence will begin, for a total of 12 weeks of treatment.
- Educational (Type: OTHER): Participants will be randomized to receive either home hypnotherapy or an educational program. The control group will receive an educational digital audio program on MP3 players. These digital audio files will contain general information about FCP and FGIDs. These audio files will be similar to the intervention audio files in length. Patients will be instructed to begin listening on the day of randomization. Patients will be instructed to continue their other medical treatment for chest pain during the study. The control group will be assessed at the same times as the HHT group.

Based on this trial design, predict the completion outcome and termination type (if applicable).